Just a moment, the page is loading...

GSK-116485




Immunogenicity and safety study of two formulations of GlaxoSmithKline (GSK) Biologicals’ pneumococcal vaccine (2830929A and 2830930A) when administered in healthy infants
GSK2830929A; GSK2830930A
116485
NCT01616459 2011-005743-27
Streptococcus pneumoniae
Phase 2
June 2019